Properties |
Information |
PhytoCAT-ID |
PhytoCAT-1907 |
Phytochemical name or plant extracts |
Annurca apple polyphenol extract (APE) |
PMID |
28766690 |
Literature evidence |
Altogether our data indicate that APE, at elevated concentrations, acts as a potent pro-oxidant and antiproliferative agent able to downregulate ERK1/2 pathway leading to cell cycle inhibition and apoptosis and provides a rationale for its potential use in the development of novel therapeutics towards breast cancer. |
IUPAC name |
NA |
Phytochemicals’ class or type of plant extracts |
Polyphenol extract |
Source of phytochemicals or plant Extracts |
Malus pumila Miller cv Annurca |
|
Geographical availability |
Afghanistan, Kazakhstan, Kirgizstan, Pakistan, Tadzhikistan, Uzbekistan, Xinjiang |
Plant parts |
Fruits |
Other cancers |
Breast cancer |
Target gene or protein |
p53, p21, Cyclin D1, ERK1/2 phosphorylation, Bax, Bcl-2 , Caspase 9,Caspase 6, Caspase 7, PARP |
Gene or Protein evidence |
Immunoblot analysis demonstrated that APE treatment increases the levels of p53 and p21, downregulates the expression of the cell cycle regulatory protein cyclin D1, and inhibits ERK1/2 phosphorylation. Moreover, APE treatment caused a marked increase of pro-apoptotic Bax/Bcl-2 ratio paralleled by caspase-9, -6, -7, and poly(ADP ribose) polymerase cleavage. |
Target pathways |
ERK1/2 pathway |
IC50 |
In contrast, a prolonged incubation of 48 h resulted in a severe loss of cell viability that decreases to 43.5%, a value near the IC50, in the presence of APE 500 µM EqC. |
Potency |
Altogether our data indicate that APE, at elevated concentrations, acts as a potent pro-oxidant and antiproliferative agent able to downregulate ERK1/2 pathway leading to cell cycle inhibition and apoptosis and provides a rationale for its potential use in the development of novel therapeutics towards breast cancer. |
Cell line/ mice model |
MCF-7 |
Additional information |
Results showed that at 500 µM catechin equivalent (EqC) APE acts as a pro-oxidant increasing thiobarbituric acid-reactive species cell content of approximately 6-fold more than the untreated cells. |
PubChem ID |
NA |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:726372-1 |
Safety |
NA |